Hydroxychloroquine synergizes with anti-PD-1 immune checkpoint blockade in squamous carcinoma of the head and neck. (October 2022) - Vyas, A.; Cruz-Rangel, S.; Khan, N.; Ferris, R.; Bruno, T.; Schmitt, N.; Kiselyov, K.; Duvvuri, U.